STOCK TITAN

Moolec Science Stock Price, News & Analysis

MLEC Nasdaq

Welcome to our dedicated page for Moolec Science news (Ticker: MLEC), a resource for investors and traders seeking the latest updates and insights on Moolec Science stock.

Moolec Science SA (MLEC) leverages groundbreaking Molecular Farming technology to develop sustainable animal proteins in plants, redefining food ingredient innovation. This dedicated news hub provides investors and industry stakeholders with timely updates on corporate developments, scientific breakthroughs, and market positioning.

Access authoritative information on MLEC's financial announcements, product launches, and strategic partnerships. Track regulatory milestones including USDA-APHIS clearances and patent approvals that validate the company's scientific approach. Discover updates on flagship products like Piggy Sooy and GLASO safflower oil driving the alternative protein sector.

Our curated collection features earnings reports, R&D advancements, and commercial partnerships essential for monitoring MLEC's growth in sustainable biotechnology. Stay informed about production scaling efforts in Argentina and global market expansions through verified primary sources.

Bookmark this page for streamlined access to Moolec Science's evolving role in food technology. Regularly updated to serve as your definitive resource for understanding MLEC's impact on molecular farming and plant-based protein solutions.

Rhea-AI Summary

Moolec Science SA (NASDAQ:MLEC) has signed a three-year offtake agreement with a major global consumer packaged goods and pet food company for its GLASO™ product, a high-GLA safflower oil. The agreement covers US territory with an initial estimated volume of 50 tons for 2025. GLASO™ contains almost 3 times more GLA than conventional sources, making it the most concentrated GLA oil available.

Moolec has also secured agreements with farmers for safflower cultivation and an industrial partner for downstream processing, ensuring a controlled supply chain. This milestone demonstrates Moolec's ability to scale production and meet growing demand for sustainable nutritional ingredients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.75%
Tags
none
-
Rhea-AI Summary

Moolec Science (NASDAQ:MLEC) has released its business update for the third quarter of Fiscal Year 2024, ending March 31, 2024. Key highlights include the USDA-APHIS regulatory approval of their patented soybean product, Piggy Sooy™, and progress in the GLASO™ safflower platform. Financially, normalized revenues and other income increased by approximately $1.3 million year-over-year due to the consolidation of the soy-protein ingredient business. However, R&D, administrative, and other expenses rose to $2.3 million, a 68% year-over-year increase, largely due to non-cash items. Operational cash utilization for the quarter was around $2.6 million, with $1.4 million allocated to reducing accounts payable. CEO Gastón Paladini and CFO José López Lecube expressed optimism about the company's achievements and future prospects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
-
Rhea-AI Summary

Moolec Science (NASDAQ: MLEC), a company specializing in Molecular Farming to produce animal proteins in plants, will release its Third Quarter Fiscal Year 2024 Business Update on May 30, 2024, before market opening.

CEO Gastón Paladini, CFO José López Lecube, and CSO Amit Dhingra will host a live conference call at 08:30 a.m. ET the same day, followed by a Q&A session. The conference call will feature a presentation available during the webcast, with a replay and PDF version accessible two hours post-event on the company's Investor Relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
conferences earnings
Rhea-AI Summary

Moolec Science SA (NASDAQ: MLEC) announced the granting of a patent in the United States for its SPC2 product produced in safflower with Molecular Farming technology. This patent provides exclusivity until 2041, showcasing Moolec's innovative approach in the industrial biotech sector. The technology involves safflower plants engineered with DNA sequences to enhance bovine chymosin expression, paving the way for new proteins and products. Moolec's Chief Science Officer highlighted the significance of this patent in expanding opportunities for the company's safflower platform and driving innovation in sustainable biotechnology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.65%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
76.43%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.69%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
conferences earnings
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.99%
Tags
none

FAQ

What is the current stock price of Moolec Science (MLEC)?

The current stock price of Moolec Science (MLEC) is $6.01 as of July 2, 2025.

What is the market cap of Moolec Science (MLEC)?

The market cap of Moolec Science (MLEC) is approximately 28.8M.
Moolec Science

Nasdaq:MLEC

MLEC Rankings

MLEC Stock Data

28.80M
876.33k
81.53%
0.18%
0.32%
Biotechnology
Healthcare
Link
Luxembourg
Luxembourg